BRIDGEBIO PHARMA INC's ticker is BBIO and the CUSIP is 10806X102. A total of 205 filers reported holding BRIDGEBIO PHARMA INC in Q1 2021. The put-call ratio across all filers is 1.92 and the average weighting 0.8%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $12,289,844 | +136.1% | 466,054 | +54.0% | 0.01% | +100.0% |
| Q2 2023 | $5,206,440 | +75873.2% | 302,700 | -26.8% | 0.00% | -25.0% |
| Q1 2023 | $6,853 | +969.1% | 413,369 | +391.1% | 0.00% | – |
| Q4 2022 | $641 | -100.0% | 84,177 | -92.8% | 0.00% | -100.0% |
| Q3 2022 | $11,583,000 | +111.9% | 1,165,308 | +93.6% | 0.01% | +133.3% |
| Q2 2022 | $5,465,000 | -47.1% | 601,867 | -40.9% | 0.00% | -50.0% |
| Q1 2022 | $10,331,000 | -60.7% | 1,017,809 | -35.4% | 0.01% | -57.1% |
| Q4 2021 | $26,289,000 | +136.5% | 1,576,073 | +564.4% | 0.01% | +100.0% |
| Q3 2021 | $11,118,000 | +29.3% | 237,215 | +68.2% | 0.01% | +40.0% |
| Q2 2021 | $8,596,000 | +233.6% | 141,011 | +237.0% | 0.01% | +150.0% |
| Q1 2021 | $2,577,000 | -64.3% | 41,842 | -58.8% | 0.00% | -60.0% |
| Q4 2020 | $7,214,000 | +457.5% | 101,442 | +155.7% | 0.01% | +150.0% |
| Q2 2020 | $1,294,000 | -81.1% | 39,680 | -83.2% | 0.00% | -86.7% |
| Q1 2020 | $6,850,000 | +754.1% | 236,200 | +531.9% | 0.02% | +1400.0% |
| Q3 2019 | $802,000 | -92.2% | 37,382 | -90.2% | 0.00% | -93.3% |
| Q2 2019 | $10,246,000 | – | 379,919 | – | 0.02% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Aisling Capital Management LP | 3,835,722 | $103,449,000 | 44.18% |
| Kohlberg Kravis Roberts & Co. L.P. | 36,900,661 | $995,211,000 | 12.26% |
| SC US (TTGP), LTD. | 2,544,738 | $68,632,000 | 4.69% |
| Cormorant Asset Management, LP | 2,780,885 | $75,000,000 | 4.31% |
| Perceptive Advisors | 6,706,268 | $180,868,000 | 4.15% |
| VIKING GLOBAL INVESTORS LP | 26,620,991 | $717,968,000 | 3.22% |
| Hillhouse Capital Management | 2,035,790 | $54,905,000 | 1.75% |
| Alpine Group USVI, LLC | 20,000 | $539,000 | 1.70% |
| HHLR ADVISORS, LTD. | 2,352,900 | $63,458,000 | 1.42% |
| SCGE MANAGEMENT, L.P. | 588,235 | $15,865,000 | 0.79% |